Stocks in news: RIL, Airtel, HDFC Bank, Vedanta, UPL, Info Edge, Bharat Forge

Stocks in news: RIL, Airtel, HDFC Bank, Vedanta, UPL, Info Edge, Bharat Forge

Following is the list of top stocks that are supposed to be in focus in the trading session of Tuesday based on the latest developments.

Reliance Industries: On February 23, the company said that it is turning its Oil-to-Chemicals (O2C) business into an independent subsidiary. RIL announced that it will be in control of 100 percent management in the new subsidiary.

HDFC Bank: The SAT or the Securities Appellate Tribunal has passed a Sebi order that was seen to impose a fine of Rs 1 crore on HDFC Bank for introducing securities pledged by stockbroker BRH Wealth Kreators, until further orders.

APL Apollo: Apollo allows commercial paper worth of Rs 75 crore to ICICI Prudential Ultra Short Term Fund.

Bharti Airtel: The telecom operator of Bharti Airtel will meet several global fixed income investors on or after February 23, this year, to take a decision on the issuance of foreign currency notes.

Vedanta: GR Arun Kumar has reportedly resigned as a whole-time director & chief financial officer of the company.

Bharat Forge: The company has forged a pact with Paramount Group which is a global aerospace and technology firm that manufactures armored vehicles in the country.

Info Edge: Online food delivery firm, Zomato has raised over Rs 1,800 crore in funding from Tiger Global, Kora, and others. This valued the online food ordering platform at $5.4 billion.

UPL: The company reported a fire that broke out at the Jagadia unit and is shut down at the moment. Fortunately, no fatality was reported.

Vimta Labs: The company appointed Narahai Naidu as its Chief Financial Officer as of February 22, 2021.

IRB Infrastructure Developers: The board of directors approved of the allotment of unlisted, secured, redeemable, and nonconvertible debentures aggregating to around Rs 2,184.55 crore on a private placement to India Toll Roads.

Pharma stocks: Alkem Labs, Ajanta Pharma, and Sun Pharma all reportedly received a US FDA nod for generic Northern.


I have read the Privacy Policy & Agree to Terms & Conditions and authorize Dialabank & its partner institutions to Call or SMS me with reference to my application.